Chen Z, Kelly JR, Morales JE, Sun RC, De A, Burkin DJ, et al
Vendor picks inside
Ozempic injection is approved to: help manage type 2 diabetes in adults lower the risk of serious heart problems in adults who have type 2 diabetes and heart disease lower the risk of worsening kidney disease and death from cardiovascular (heart or blood vessel) disease in adults who have type 2 diabetes and chronic (long-term) kidney disease However, doctors may also prescribe Ozempic off-label for weight loss in: adults and children ages 12 years and older with obesity adults with overweight and at least one weight-related condition, such as high blood pressure or high cholesterol To find out whether Ozempic may be right for you, talk with your doctor
[11] Saxenda (liraglutide) [prescribing information]
In November 2023, AstraZeneca and Eccogene signed an exclusive license agreement for ECC5004, an investigational oral once-daily GLP-1RA for treating obesity, type 2 diabetes, and other cardiometabolic conditions
Tirzepatide tolerance does not transfer cleanly to retatrutide because of the glucagon receptor